Abstract |
Twenty five cases of advanced postmenopausal breast cancer patients were treated with bisbromoacetyl hexestrol 3 CR and 5 PR were achieved. The response rate was 32%, and the average duration of remission 6 months. Vaginal bleeding was seen in 9 cases, 4 of whom were compelled to discontinue treatment.
|
Authors | T Zhao, G He |
Journal | Tumori
(Tumori)
Vol. 74
Issue 6
Pg. 693-5
(Dec 31 1988)
ISSN: 0300-8916 [Print] United States |
PMID | 2852862
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Hexestrol
- bis(bromoacetyl)hexestrol
|
Topics |
- Aged
- Antineoplastic Agents
(therapeutic use)
- Breast Neoplasms
(drug therapy)
- Female
- Hexestrol
(analogs & derivatives, therapeutic use)
- Humans
- Menopause
- Middle Aged
|